Mani Mohindru
Chief Executive Officer · Cardiff Oncology, Inc.
- 2025
- Jul 16, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mani Mohindru files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sean A. McCarthy - $1.23M in CTMX purchases and sales in the last 12 months
- Gary W. Pace - $1.04M in CRDF purchases and sales in the last 12 months
- Marcia Belvin - $202K in CTMX purchases and sales in the last 12 months
- Yu-Waye Chu - $137K in CTMX purchases and sales in the last 12 months
- Christopher Ogden - $129K in CTMX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mani Mohindru?
Mani Mohindru is a corporate insider, tracked as Chief Executive Officer of Cardiff Oncology, Inc. (CRDF). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Mani Mohindru last file a Form 4?
The most recent primary Form 4 on record is dated 16 July 2026, one of 6 filings going back to 2025.
Has Mani Mohindru been buying or selling stock?
Recorded transactions: 3 open-market purchases ($80K) and 0 open-market sales across all tracked filings.
